MetLife, Inc. (NYSE:MET) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 12,434,952 shares, a decrease of 21.6% from the October 31st total of 15,854,719 shares. Currently, 1.4% of the company’s shares are short sold. Based on an average daily volume of 4,307,232 shares, the days-to-cover ratio is currently 2.9 days.

In other news, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the sale, the insider now directly owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the sale, the insider now directly owns 25,181 shares in the company, valued at $1,367,076.49. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Farmers National Bank acquired a new position in MetLife during the second quarter worth $118,000. Ffcm LLC raised its holdings in shares of MetLife by 2,020.8% in the third quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock valued at $119,000 after purchasing an additional 2,142 shares during the last quarter. Cable Hill Partners LLC raised its holdings in shares of MetLife by 246.6% in the third quarter. Cable Hill Partners LLC now owns 2,412 shares of the financial services provider’s stock valued at $125,000 after purchasing an additional 1,716 shares during the last quarter. Valeo Financial Advisors LLC purchased a new stake in shares of MetLife in the third quarter valued at about $151,000. Finally, First Mercantile Trust Co. raised its holdings in shares of MetLife by 3.4% in the second quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock valued at $161,000 after purchasing an additional 97 shares during the last quarter. Hedge funds and other institutional investors own 76.37% of the company’s stock.

MetLife (MET) opened at $53.61 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. MetLife has a 1-year low of $44.26 and a 1-year high of $55.91. The firm has a market cap of $56,524.24, a price-to-earnings ratio of 10.33, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.19. MetLife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The firm had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. During the same quarter in the prior year, the company posted $1.28 earnings per share. The business’s revenue was up 1.7% on a year-over-year basis. equities analysts forecast that MetLife will post 4.43 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 13th. Shareholders of record on Monday, November 6th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, November 3rd. This represents a $1.60 annualized dividend and a yield of 2.98%. MetLife’s payout ratio is -320.00%.

Several research analysts recently issued reports on MET shares. TheStreet lowered shares of MetLife from a “b-” rating to a “c+” rating in a research note on Monday, August 21st. Goldman Sachs Group started coverage on shares of MetLife in a research note on Wednesday, October 18th. They set a “conviction-buy” rating and a $61.00 target price on the stock. ValuEngine lowered shares of MetLife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 9th. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research note on Monday, August 7th. Finally, Zacks Investment Research raised shares of MetLife from a “strong sell” rating to a “hold” rating in a research note on Monday, October 9th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $58.40.

WARNING: “MetLife, Inc. (MET) Short Interest Down 21.6% in November” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/12/02/metlife-inc-met-short-interest-down-21-6-in-november.html.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.